Skip to main content

Organon to Use BioImage Assay Technology for Compound Profiling

NEW YORK, Sept. 7 (GenomeWeb News) - Danish biotechnology company BioImage announced today that it has signed a research agreement with Organon to profile selected lead compounds using BioImage's cell-based assay technology.

 

Under the terms of the agreement, Organon will utilize a series of BioImage's Redistribution assays to perform pathway profiling on selected lead compounds produced at Organon's research and development facilities in Oss, the Netherlands.

 

Financial terms of the agreement were not disclosed.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.